A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

NCT01625377 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: tacrolimus
DRUG: everolimus
DRUG: Basiliximab
DRUG: Mycophenolic Acid
DRUG: Corticosteroids

Sponsor

Novartis Pharmaceuticals